Literature DB >> 29286543

Detecting Deception in Our Research Participants: Are Your Participants Who You Think They Are?

Mary E McCaul1,2, Gary S Wand1,2.   

Abstract

There is increasing awareness of the potential negative impacts of participant deception on research, including possibly undermining reliability and reproducibility of study findings. These deceptive individuals set their personal interests above the rules of study participation, thereby jeopardizing data quality as well as placing themselves and others at risk. The costs of participant deception are numerous. Overall, it reduces statistical power and may even result in false conclusions about efficacy and safety. To date, most studies have not utilized sufficient methods to detect rule-breaking subjects. The purpose of this article is to bring to the attention of alcohol and other drug researchers issues involving deceptive participants. The review will suggest alcohol-specific as well as more general strategies to identify and thereby minimize enrollment of these deceptive participants. Specifically, we will identify strategies that are employed in different phases of human alcohol research and advance approaches that may be helpful to the field in reducing these contaminants. As a field, we need to be more proactive in identifying the deceptive participant even at the cost of more burdensome study enrollment. In light of the systemic nature and multipronged damage that this emerging pattern of deception inflicts on clinical research, it is imperative that we each assume greater responsibility for our role in mitigating this source of research contamination.
Copyright © 2017 by the Research Society on Alcoholism.

Entities:  

Keywords:  Assessment; Biomarkers; Deception; Professional Subject; Research Recruitment

Mesh:

Year:  2017        PMID: 29286543      PMCID: PMC5785431          DOI: 10.1111/acer.13556

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  13 in total

1.  Concealment and fabrication by experienced research subjects.

Authors:  Eric G Devine; Megan E Waters; Megan Putnam; Caitlin Surprise; Katie O'Malley; Courtney Richambault; Rachel L Fishman; Clifford M Knapp; Elissa H Patterson; Ofra Sarid-Segal; Chris Streeter; Laurie Colanari; Domenic A Ciraulo
Journal:  Clin Trials       Date:  2013-07-18       Impact factor: 2.486

2.  Medical histories may be unreliable in screening volunteers for clinical trials.

Authors:  G Apseloff; J K Swayne; N Gerber
Journal:  Clin Pharmacol Ther       Date:  1996-09       Impact factor: 6.875

Review 3.  Progress in monitoring alcohol consumption and alcohol abuse by phosphatidylethanol.

Authors:  Alexandra Schröck; Annette Thierauf; Friedrich Martin Wurst; Natasha Thon; Wolfgang Weinmann
Journal:  Bioanalysis       Date:  2014-08       Impact factor: 2.681

4.  Assessing the adequacy of postexperimental inquiries in deception research and the factors that promote participant honesty.

Authors:  Ginette C Blackhart; Kelly E Brown; Travis Clark; Donald L Pierce; Kelsye Shell
Journal:  Behav Res Methods       Date:  2012-03

5.  Alcohol biomarkers in applied settings: recent advances and future research opportunities.

Authors:  Raye Z Litten; Ann M Bradley; Howard B Moss
Journal:  Alcohol Clin Exp Res       Date:  2010-04-05       Impact factor: 3.455

Review 6.  Medication Nonadherence, "Professional Subjects," and Apparent Placebo Responders: Overlapping Challenges for Medications Development.

Authors:  David J McCann; Nancy M Petry; Anders Bresell; Eva Isacsson; Ellis Wilson; Robert C Alexander
Journal:  J Clin Psychopharmacol       Date:  2015-10       Impact factor: 3.153

7.  Use of a Novel Artificial Intelligence Platform on Mobile Devices to Assess Dosing Compliance in a Phase 2 Clinical Trial in Subjects With Schizophrenia.

Authors:  Earle E Bain; Laura Shafner; David P Walling; Ahmed A Othman; Christy Chuang-Stein; John Hinkle; Adam Hanina
Journal:  JMIR Mhealth Uhealth       Date:  2017-02-21       Impact factor: 4.773

Review 8.  Phosphatidylethanol in blood as a marker of chronic alcohol use: a systematic review and meta-analysis.

Authors:  Guido Viel; Rafael Boscolo-Berto; Giovanni Cecchetto; Paolo Fais; Alessandro Nalesso; Santo Davide Ferrara
Journal:  Int J Mol Sci       Date:  2012-11-13       Impact factor: 5.923

9.  Mitigating the Effects of Nonadherence in Clinical Trials.

Authors:  Thomas M Shiovitz; Earle E Bain; David J McCann; Phil Skolnick; Thomas Laughren; Adam Hanina; Daniel Burch
Journal:  J Clin Pharmacol       Date:  2016-01-22       Impact factor: 3.126

10.  Strategies to exclude subjects who conceal and fabricate information when enrolling in clinical trials.

Authors:  Eric G Devine; Kristina R Peebles; Valeria Martini
Journal:  Contemp Clin Trials Commun       Date:  2016-12-18
View more
  3 in total

Review 1.  Methods to reduce the incidence of false negative trial results in substance use treatment research.

Authors:  Rachel L Tomko; Erin A McClure; Lindsay M Squeglia; Hayley Treloar Padovano; Aimee L McRae-Clark; Nathaniel L Baker; Matthew J Carpenter; Kevin M Gray
Journal:  Curr Opin Psychol       Date:  2019-01-28

2.  Factors associated with phosphatidylethanol (PEth) sensitivity for detecting unhealthy alcohol use: An individual patient data meta-analysis.

Authors:  Judith A Hahn; Pamela M Murnane; Eric Vittinghoff; Winnie R Muyindike; Nneka I Emenyonu; Robin Fatch; Gabriel Chamie; Jessica E Haberer; Joel M Francis; Saidi Kapiga; Karen Jacobson; Bronwyn Myers; Marie Claude Couture; Ralph J DiClemente; Jennifer L Brown; Kaku So-Armah; Mark Sulkowski; Gregory M Marcus; Sarah Woolf-King; Robert L Cook; Veronica L Richards; Patricia Molina; Tekeda Ferguson; David Welsh; Mariann R Piano; Shane A Phillips; Scott Stewart; Majid Afshar; Kimberly Page; Kathleen McGinnis; David A Fiellin; Amy C Justice; Kendall Bryant; Richard Saitz
Journal:  Alcohol Clin Exp Res       Date:  2021-05-07       Impact factor: 3.928

3.  Frequency of concealment, fabrication and falsification of study data by deceptive subjects.

Authors:  Eric G Devine; Alyssa M Pingitore; Kathryn N Margiotta; Natalia A Hadaway; Kathleen Reid; Kristina Peebles; Jae Won Hyun
Journal:  Contemp Clin Trials Commun       Date:  2021-01-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.